Cesarini J P, Daveau M, Picard F, Fournier E, Rivat L, Rivat C
Ann Dermatol Venereol. 1978 Apr;105(4):405-8.
27 patients with SSM or NM level IV and V have been submitted to a monthly evaluation of their level of 5-S-cysteinyldopa in the urine and IgG4 subclass in their sera. For 5 patients who entered the stage II of their disease during the follow-up, 3 had elevation of the 5S and 5 had large variations of IgG4. On 21 patients in clinical remission, 10 had conjunctly an increase of 5S and variations of IgG4. The predictional value of these tests is discussed.
27例患有浅表性硬化性黏液水肿（SSM）或结节性黏液水肿（NM）IV级和V级的患者接受了每月一次的尿液中5-S-半胱氨酰多巴水平和血清中IgG4亚类水平的评估。在随访期间进入疾病II期的5例患者中，3例5-S-半胱氨酰多巴水平升高，5例IgG4有较大变化。在21例临床缓解的患者中，10例同时出现5-S-半胱氨酰多巴升高和IgG4变化。对这些检测的预测价值进行了讨论。
